Intervention Protocol

You have free access to this content

Neuromuscular blocking agents for patients with acute respiratory distress syndrome

  1. Guang-Ying Zhuo1,
  2. Qing He2,*,
  3. Li J Yang1,
  4. Guan J Liu3,
  5. Jonathan N Rajan4

Editorial Group: Cochrane Anaesthesia Group

Published Online: 23 JAN 2014

DOI: 10.1002/14651858.CD010924


How to Cite

Zhuo GY, He Q, Yang LJ, Liu GJ, Rajan JN. Neuromuscular blocking agents for patients with acute respiratory distress syndrome (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No.: CD010924. DOI: 10.1002/14651858.CD010924.

Author Information

  1. 1

    West China Hospital, Sichuan University, Emergency Department, Chengdu, China

  2. 2

    The Third People's Hospital of Chengdu, Department of Respiratory Medicine, Chengdu, Sichuan, China

  3. 3

    West China Hospital, Sichuan University, Chinese Cochrane Centre, Chinese Evidence-Based Medicine Centre, Chengdu, Sichuan, China

  4. 4

    Manchester Royal Infirmary, Anaesthetics and Intensive Care, Manchester, UK

*Qing He, Department of Respiratory Medicine, The Third People's Hospital of Chengdu, Qinglong, 37#, Chengdu, Sichuan, 610031, China. hq_1919@126.com.

Publication History

  1. Publication Status: New
  2. Published Online: 23 JAN 2014

SEARCH

References

Additional references

ARDS definition taskforce 2012
  • Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307(23):2526-33. [PUBMED: 22797452]
Boyadjiev 2008
  • Boyadjiev I, Albanese J. Sedation and acute respiratory distress syndrome. Annales Francaises d Anesthesie et de Reanimation 2008;27(7-8):604-10. [MEDLINE: 18585000]
Brunello 2010
  • Brunello AG, Haenggi M, Wigger O, Porta F, Takala J, Jakob SM. Usefulness of a clinical diagnosis of ICU-acquired paresis to predict outcome in patients with SIRS and acute respiratory failure. Intensive Care Medicine 2010;36(1):66-74. [MEDLINE: 19760204]
Deem 2006
Dushianthan 2011
Forel 2006
  • Forel JM, Roch A, Marin V, Michelet P, Demory D, Blache JL, et al. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Critical Care Medicine 2006;34(11):2749-57. [MEDLINE: 16932229]
Guyatt 2008
Henry 2007
  • Fessler HE, Hess DR. Does high-frequency ventilation offer benefits over conventional ventilation in adult patients with acute respiratory distress syndrome?. Respiratory Care 2007;52:5. [MEDLINE: 17484791]
Higgins 2011
  • Higgins JPT, Green S (editors).Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
Jonsson 2006
  • Jonsson M, Gurley D, Dabrowski M, Larsson O, Johnson EC, Eriksson LI. Distinct pharmacologic properties of neuromuscular blocking agents on human neuronal nicotinic acetylcholine receptors: a possible explanation for the train-of-four fade. Anesthesiology 2006;105(3):521-33. [PUBMED: 16931985 ]
Jonsson 2009
  • Jonsson Fagerlund M, Dabrowski M, Eriksson LI. Pharmacological characteristics of the inhibition of nondepolarizing neuromuscular blocking agents at human adult muscle nicotinic acetylcholine receptor. Anesthesiology 2009;110(6):1244-52. [PUBMED: 19417616]
Latronico 2005
Malhotra 2007
Papazian 2010
  • Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. New England Journal of Medicine 2010;363(12):1107-16. [MEDLINE: 20843245]
Petrucci 2013
RevMan 5.1
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Rucker 2008
Segredo 1992
  • Segredo V, Caldwell JE, Matthay MA, Sharma ML, Gruenke LD, Miller RD. Persistent paralysis in critically ill patients after long-term administration of vecuronium. New England Journal of Medicine 1992;327:524-8. [MEDLINE: 1353252]
Sessler 2004
Ware 2000